Uveitis, an inflammation of the uvea, which encompasses the iris, ciliary body, and choroid layers of the eye, presents a complex challenge in ophthalmology. It manifests through symptoms such as eye redness, sensitivity to light, blurred vision, and discomfort, potentially leading to vision impairment if untreated. Diagnosis involves thorough eye examinations and sometimes supplementary tests like imaging or blood work to pinpoint the underlying cause, which can range from infections to autoimmune conditions or injuries.
Treatment strategies aim to quell inflammation and alleviate symptoms, often employing corticosteroid eye drops, oral medications, or injections directly into the eye. Vigilant management is crucial, as untreated uveitis can progress to severe complications such as glaucoma or cataracts. Timely intervention and ongoing care are essential to safeguarding eye health and preserving long-term vision.
Background: Uveitis pattern varies according to regional, demographic, and racial factors. Therefore, an epidemiological study of the distribution of uveitis in various regions in India is likely to…
Aims: This comprehensive review aims to evaluate the mechanism, long-term safety, efficacy, and disease-specific applications of tumour necrosis factor-alpha (TNF-α) inhibitors in the treatment of…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original Uveitis work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Uveitis research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Uveitis track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Uveitis. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Uveitis are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Uveitis track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
